| abstract |
Compound of formula (I): ** Formula ** in which: - R1 is chosen from a hydrogen atom, a C1-C6 alkyl group and a C1-C6 halogenoalkyl; - R2, R3, identical or different, are chosen between a hydrogen atom and a C1-C6 alkyl group; as well as the pharmaceutically acceptable salts of this compound, for use in the treatment or prevention of an undesirable effect induced by an anticancer agent, said undesirable effect being neurotoxicity. |